ATRA -long- catalyst play
developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
This is not a financial advice!
Upcoming catalysts 06/30/2024 and 06/30/2025
Block buys recently and passive stakes
Rel. Vol. on 03/08/2024 at 4.32
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Keep an eye on 1.0 / 1.2 / 1.4 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 0.5 (very tight)
TPs approx. 2.0 maybe even 5.7
Most info on the chart.
Trade carefully!
This is not a financial advice!
Upcoming catalysts 06/30/2024 and 06/30/2025
Block buys recently and passive stakes
Rel. Vol. on 03/08/2024 at 4.32
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Keep an eye on 1.0 / 1.2 / 1.4 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 0.5 (very tight)
TPs approx. 2.0 maybe even 5.7
Most info on the chart.
Trade carefully!
Note
Atara Biotherapeutics, Inc. Passive Stake (FormSC13G)Trade closed: stop reached
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.